News

Published on 12 May 2023 on Benzinga via Yahoo Finance

Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company...


Article preview image

Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (formerly CY6463) and CY3018, to a new private company ("NewCo") formed by certain current Cyclerion shareholders and new investors who have agreed to invest $81 million.

NASDAQ.CYCN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
3 US Penny Stocks With Market Caps Over $10M To Consider

As investors navigate a mixed market landscape, with major indices showing varied performances am...

Simply Wall St. · via Yahoo Finance 2 Feb 2025

3 US Penny Stocks With Market Caps Under $100M

As U.S. stocks experience fluctuations amid anticipation of key inflation data and interest rate ...

Simply Wall St. · via Yahoo Finance 10 Dec 2024

12 Best Biotech Penny Stocks to Invest In

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip ou...

Insider Monkey via Yahoo Finance 24 Mar 2024

Cyclerion Therapeutics' Market Cap Drops To US$5.0m Leaving Insiders With Losses

Insiders who bought US$1.95m worth of Cyclerion Therapeutics, Inc.'s (NASDAQ:CYCN) stock at an av...

Simply Wall St. via Yahoo Finance 29 Nov 2023

The Petri Dish: Alexion buys Pfizer gene therapies in $1B deal; Peter Hecht's plan to save Cyclerion...

Peter Hecht, the co-founder and CEO of embattled biotech Cyclerion Therapeutics Inc. (Nasdaq: CYC...

American City Business Journals 5 Aug 2023

Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company...

Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (form...

Benzinga via Yahoo Finance 12 May 2023

GreenLight Biosciences lays off a quarter of its team

GreenLight Biosciences Holdings Inc. is laying off a quarter of its staff eight months after it w...

American City Business Journals 27 Oct 2022

Cyclerion Therapeutics lays off nearly half of workforce

Cyclerion Therapeutics Inc. is culling its workforce as it narrows its focus to mitochondrial...

American City Business Journals 7 Oct 2022

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.15% By Investing.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.15%

Investing.com 6 Oct 2022

Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction

Cyclerion Therapeutics Inc (NASDAQ: CYCN) is reprioritizing development programs and focusing res...

Benzinga via Yahoo Finance 6 Oct 2022